The 2012 Leading Diagnostic Imaging Companies Product Portfolio Analyses

VPGMarketResearch.com
March 28, 2012
230 Pages - SKU: VPG3811496
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics The Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the asset purchase agreements  |  read more...
USD 2,995
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter  |  read more...
USD 1,995
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
12/1/2014 | published by: Current Partnering
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the  |  read more...
USD 3,295
Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2014 Update
12/9/2014 | published by: GlobalData
Summary Chembio Diagnostics, Inc. (Chembio) together with its wholly owned subsidiary Chembio Diagnostic Systems, Inc., undertakes the development, manufacture and marketing of point-of-care diagnostic (POCs) tests that detect infectious diseases. The major commercially available products of  |  read more...
USD 750
Ascenion GmbH - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Ascenion GmbH (Ascenion) is a life science service company. It provides science and research promotion services. The product line of the company includes therapeutic, diagnostic, medical technology, materials and nutrition products. The company provides services,  |  read more...
USD 750
Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Biocept, Inc. (Biocept) is a diagnostics service provider. The company provides molecular oncology laboratory services. Its services include prognostic CTC enumeration for various solid tumors, levels of sensitivity to detect CTCs, and molecular testing on  |  read more...
USD 750
Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325413
12/10/2014 | published by: Plunkett Research, Ltd.
Medical Diagnostics, Reagents, Assays and Test Kits Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325413 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that  |  read more...
USD 1,995
Cancer Diagnostics Partnering Terms and Agreements
12/1/2014 | published by: Current Partnering
Cancer Diagnostics Partnering Terms and Agreements The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.  |  read more...
USD 2,995
BioMedomics, Inc - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary BioMedomics, Inc. (BioMedomics) is a medical diagnostics company. The company conducts research and develops assays and technologies for use in molecular diagnostics. Its diagnostic platform technologies include time-resolved lateral flow immunoassay platform, nanotube based highly  |  read more...
USD 750
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update
12/10/2014 | published by: GlobalData
Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection and other chronic diseases. Its products include rapid  |  read more...
USD 750
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 1,850  
    Global Site License Fulfilled by Publisher  USD 3,900  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!